Trial name or title	Efficacy of lumiracoxib in relieving moderate to severe post-dental surgery pain, compared to both placebo and celecoxib
Methods
Participants	Male and females aged 17 years and over who require extraction of two or more partially impacted or fully bony impacted third molars. At least one of the extractions must be mandibular
Interventions	lumiracoxib 400 mg celecoxib 400 mg placebo
Outcomes	Superiority of a single dose of lumiracoxib 400 mg compared to placebo and celecoxib 400 mg based on a Summed (time weighted) Pain Intensity Difference calculated over 0-8 hours post-dose (SPID 8)
Starting date	February 2006
Contact information
Notes